SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001607062-15-000015
Filing Date
2015-01-22
Accepted
2015-01-21 19:09:46
Documents
5
Period of Report
2015-01-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K rgbp20150120form8k.htm 8-K 26016
2 CERTIFICATE OF DESIGNATIONS rgbp20150120form8kex3i.htm EX-3 7361
3 EMPLOYMENT AGREEMENT BETWEEN REGEN BIOPHARMA, INC. AND THOMAS ICHIM rgbp20150120form8kex10_1.htm EX-10.1 54255
4 EMPLOYMENT AGREEMENT BETWEEN REGEN BIOPHARMA, INC AND CHRISTINE ICHIM rgbp20150120form8kex10_2.htm EX-10.2 53126
5 AMENDMENT TO SUBLEASE AGREEMENT rgbp20150120form8kex10_3.htm EX-10.3 4315
  Complete submission text file 0001607062-15-000015.txt   146277
Mailing Address 4700 SPRING ST #304 LA MESA CA 91942
Business Address 4700 SPRING ST #304 LA MESA CA 91942 619-702-1404
Regen BioPharma Inc (Filer) CIK: 0001589150 (see all company filings)

IRS No.: 455192997 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 333-191725 | Film No.: 15539913
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1